Drugs / Human Growth Hormone (1-134)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01007071 | Nov 2009 → Dec 2012 | hypopituitarism | Stanford University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human Growth Hormone (1-134) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01007071 ↗ |
| Route | Subcutaneous | “growth hormone is dosed sc on a daily basis” NCT01007071 ↗ |